Structural and cellular mechanisms of peptidyl-prolyl isomerase Pin1-mediated enhancement of Tissue Factor gene expression, protein half-life, and pro-coagulant activity by Kurakula, K. et al.
haematologica | 2018; 103(6) 1073
Received: October 23, 2017.
Accepted: March 1, 2018.
Pre-published: March 15, 2018.
©2018 Ferrata Storti Foundation
Material published in Haematologica is covered by copyright.
All rights are reserved to the Ferrata Storti Foundation. Use of
published material is allowed under the following terms and
conditions: 
https://creativecommons.org/licenses/by-nc/4.0/legalcode. 
Copies of published material are allowed for personal or inter-
nal use. Sharing published material for non-commercial pur-
poses is subject to the following conditions: 
https://creativecommons.org/licenses/by-nc/4.0/legalcode,
sect. 3. Reproducing and sharing published material for com-
mercial purposes is not allowed without permission in writing
from the publisher.
Correspondence: 
c.j.devries@amc.nl  or  msen@uh.edu
Ferrata Storti
Foundation
Haematologica 2018
Volume 103(6):1073-1082
ARTICLECoagulation & its Disorders
doi:10.3324/haematol.2017.183087
Check the online version for the most updated
information on this article, online supplements,
and information on authorship & disclosures:
www.haematologica.org/content/103/6/1073
Tissue Factor is a cell-surface glycoprotein expressed in various cellsof the vasculature and is the principal regulator of the blood coag-ulation cascade and hemostasis. Notably, aberrant expression of
Tissue Factor is associated with cardiovascular pathologies such as ath-
erosclerosis and thrombosis. Here, we sought to identify factors that reg-
ulate Tissue Factor gene expression and activity. Tissue Factor gene
expression is regulated by various transcription factors, including activat-
ing protein-1 and nuclear factor-κ B. The peptidyl-prolyl isomerase Pin1
is known to modulate the activity of these two transcription factors, and
we now show that Pin1 augments Tissue Factor gene expression in both
vascular smooth muscle cells and activated endothelial cells via activat-
ing protein-1 and nuclear factor-κ B signaling. Furthermore, the cytoplas-
mic domain of Tissue Factor contains a well-conserved phospho-Ser258-
Pro259 amino-acid motif recognized by Pin1. Using co-immunoprecipi-
tation and solution nuclear magnetic resonance spectroscopy, we show
that the WW-domain of Pin1 directly binds the cytoplasmic domain of
Tissue Factor. This interaction occurs via the phospho-Ser258-Pro259
sequence in the Tissue Factor cytoplasmic domain and results in
increased protein half-life and pro-coagulant activity. Taken together, our
results establish Pin1 as an upstream regulator of Tissue Factor-mediated
coagulation, thereby opening up new avenues for research into the use
of specific Pin1 inhibitors for the treatment of diseases characterized by
pathological coagulation, such as thrombosis and atherosclerosis.  
Structural and cellular mechanisms of 
peptidyl-prolyl isomerase Pin1-mediated
enhancement of Tissue Factor gene 
expression, protein half-life, and pro-coagulant
activity
Kondababu Kurakula,1,2,* Duco S. Koenis,1,* Mark A. Herzik Jr,3,4 Yanyun Liu,3
John W. Craft Jr,3 Pieter B. van Loenen,1 Mariska Vos,1 M. Khang Tran,1
Henri H. Versteeg,5 Marie-José T.H. Goumans,2 Wolfram Ruf,6,7
Carlie J.M. de Vries1,# and Mehmet Şen3,#
1Department of Medical Biochemistry, Amsterdam Cardiovascular Sciences, Academic
Medical Center, University of Amsterdam, the Netherlands; 2Department of Cell and
Chemical Biology, Leiden University Medical Center, the Netherlands;  3Department of
Biology and Biochemistry, Chemical Biology Interdisciplinary Program, University of
Houston, TX, USA; 4Department of Integrative Structural and Computational Biology, The
Scripps Research Institute, La Jolla, CA, USA; 5The Einthoven Laboratory for
Experimental Vascular Medicine, Leiden University Medical Center, the Netherlands;
6Center for Thrombosis and Hemostasis, University Medical Center, Mainz, Germany and
7Department of Immunology and Microbial Science, The Scripps Research Institute, La
Jolla, CA, USA
*KK and DSK contributed equally to this work. #CJMdV and MS contributed equally to this work.
ABSTRACT
Introduction
Tissue Factor (TF), an integral cell-surface glycoprotein, is the initiator of the blood
coagulation cascade and a key regulator of hemostasis.1,2 Aberrant expression of TF
plays a crucial role in several coagulation-driven pathologies, such as thrombosis, ath-
erosclerosis, and acute coronary syndromes,2-4 but also in endotoxemia, angiogenesis,
and cancer.5-8 Many vascular cells express TF constitutively, including smooth muscle
cells (SMCs), pericytes, and adventitial fibroblasts, while TF expression is unde-
tectable in vascular endothelial cells (ECs).1 However, in both ECs and SMCs, the
expression and activity of TF can be enhanced by pro-inflammatory signaling mole-
cules such as tumor necrosis factor-α (TNF-α) and
lipopolysaccharides (LPS), which induce TF expression via
activating protein 1 (AP-1) and nuclear factor-kappa B (NF-
κB) signaling.1,9,10 Consistently, inflammation-induced coag-
ulation is completely abrogated by inhibition of TF activity
in vivo.11 
The TF protein contains two fibronectin type-III
ectodomains, a single type-I transmembrane domain, and a
twenty-amino acid cytoplasmic domain (TFCD), which
plays an important role in several of the above-mentioned
pathologies that involve TF.6-8 The TFCD can undergo mul-
tiple post-translational modifications, including palmitoyla-
tion at residue Cys245, phosphorylation at residues Ser253
and Ser258 by PKC-α and p38α-kinase, respectively, and
ubiquitination at residue Lys255.12-15 These modifications
act in concert to attenuate the interaction of the TFCD with
the membrane lipid bilayer, as well as make it accessible to
other interacting proteins that regulate TF activity.13,14,16 
Peptidyl-prolyl cis-trans isomerase, NIMA-Interacting 1
(Pin1) is an enzyme that catalyzes cis-trans isomerization of
proline residues that are preceded by a phosphorylated ser-
ine or threonine (a pSer/pThr-Pro motif) within its target
proteins. The C-terminal isomerase domain of Pin1 binds
the motif and catalyzes proline cis-trans isomerization,
while the N-terminal WW-domain is responsible for medi-
ating protein-protein interactions and target specificity.17-19
Conformational changes induced by Pin1-catalyzed proline
isomerization have been shown to alter the phosphoryla-
tion, localization, stability, protein-protein interactions, and
transcriptional activity of its target proteins, which include
c-Jun, NF-κB, AP-1, p53, β-catenin, and the nuclear recep-
tors PPARg and Nur77.20-22 
Here, we report that Pin1 enhances TF gene expression in
activated vascular cells, and directly interacts with TF pro-
tein through a pSer258-Pro259 motif in the TFCD. We pro-
vide the solution structure of the TFCD in complex with
the WW-domain of Pin1, which shows that this interaction
requires both phosphorylation of Ser258 as well as trans-
configuration of the pSer258-Pro259 peptide bond in the
TFCD. Functionally, we demonstrate that Pin1 increases
the protein half-life and pro-coagulant activity of TF in
human vascular cells.
Methods
Mice
Mice in which the cytoplasmic domain of endogenous TF is
deleted (TFDCD mice)23 and wild-type litter mates were maintained
under pathogen-free conditions at the Scripps Research Institute
Animal Facility with approved protocols of the institutional
Animal Care and Use Committee (protocols #08-0008 and #08-
0009).
Cell culture
Human umbilical vein endothelial cells (HUVECs) and smooth
muscle cells (SMCs) were isolated from umbilical cords anony-
mously collected at the Academic Medical Center, as previously
described,22 in accordance with the institute’s ethical guidelines
and with approval from the institute's Medical Ethical Committee.
Please see the Online Supplementary Methods for a detailed descrip-
tion of cell culture conditions.
Lentiviral transductions
Recombinant lentiviral particles encoding Pin1, shPin1, or back-
bone control constructs were produced as previously described.22
Cells were transduced at a multiplicity of infection of 100 for 24
hours (h), after which the medium was refreshed and cells were
cultured for an additional 24 h before starting experiments.
Transfections and luciferase assays
HEK293T cells and SMCs were transfected using the CalPhos
Mammalian Transfection Kit (Clontech) or Lipofectamine 3000
(Invitrogen), respectively. Cells were transfected according to the
manufacturer’s instructions with wild-type, AP-1 binding site
mutated, or NF-kB binding site mutated TF promoter luciferase
reporter constructs (a gift from Nigel Mackman;24 Addgene
#15442-15444) together with Pin1 or Pin1 mutants (described by
van Tiel et al.22). The pRL-TK Renilla-reporter was co-transfected as
internal control. After 24 h, cells were stimulated with 100 ng/mL
12-O-Tetradecanoylphorbol-13-acetate (PMA; Sigma) for 6 h. For
NF-κB or AP-1 signaling inhibition, cells were treated with vehicle
(DMSO), 10 mM BAY-117085 (Calbiochem), or 10 mM SP600125
(SelleckChem). Assays were performed using the dual-luciferase
reporter assay and a Glomax Multi detection system (Promega).
Nuclear magnetic resonance spectroscopy
Nuclear magentic resonance (NMR) experiments were per-
formed on Bruker DRX 600 MHz and 800 MHz spectrometers
equipped with triple resonance 1H/13C/15N optimized for proton
detection at 300K. Acquired data were converted from Bruker
XWINNMR format to NMRVIEW v.5.3 format using NMRpipe
software.25,26 All spectra were analyzed using NMRVIEW. All
experiments were performed at the UH NMR Facility at the
University of Houston. Please see the Online Supplementary
Methods for a detailed description of NMR spectroscopy proce-
dures.
TF protein half-life assays
Smooth muscle cells (SMCs) or HEK293T cells were transfected
with Pin1 or Pin1 mutants and either TF or TFDCD constructs. After
24 h, transfected cells were treated with 50 mg/mL cycloheximide
(Sigma) for times indicated. TF protein levels were quantified by
western blotting. 
TF activity assays
Tissue factor activity was determined in SMCs, HUVECs, and
EC-RF24 cells as previously described.27 Briefly, transduced cells
were serum-starved overnight followed by stimulation with 50
ng/mL TNF-α (Peprotech) for 3 h. Cells were washed with PBS
and incubated with 1 nM human Factor VIIa and 100 nM human
Factor X (Kordia) at 37°C. Supernatant samples were collected in
100 mM EDTA, 50 mM Tris after 10, 20, and 30 minutes (min),
incubated with 0.4 mM of FXa chromogenic substrate S-2222, and
absorbance was measured at 405 nm.
Statistical analysis
Data are presented as mean±Standard Error of Mean.
Significance was determined by unpaired two-tailed Student’s t-
test or one- or two-way ANOVA with Bonferroni post-hoc correc-
tion as indicated in the figure legends. P<0.05 was considered sta-
tistically significant.
Results
Pin1 enhances TF gene expression via activation of 
NF-κB and AP-1
Pin1 modulates the activity of various transcription fac-
tors involved in TF gene expression.14,15 Therefore, we ini-
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tiated our study by assessing the effect of Pin1 on TF gene
expression. TF gene expression was measured in cultured
ECs and SMCs after Pin1 gain and loss-of-function. Pin1
overexpression significantly increased TF mRNA levels in
human SMCs and TNF-α-activated ECs, while knock-
down of Pin1 by siRNA or Pin1 isomerase activity inhibi-
tion with Juglone28 resulted in significantly decreased TF
mRNA expression in ECs (Figure 1A and B). Additionally,
pharmacological inhibition of Pin1 isomerase activity with
Juglone significantly decreased PMA-induced activation of
the TF promoter in HEK293T cells (Figure 1C).
The promoter of the TF gene contains binding motifs
for NF-κB, AP-1, Sp1, and Egr-1, which are important tran-
scription factors for both basal expression and stimulus-
specific induction of TF expression.14,15 Consistent with
our gene expression data, Pin1 overexpression markedly
enhanced the activity of the wild-type TF promoter
reporter construct in both HEK293T cells and SMCs
(Figure 1D-F). However, this activation of the TF promoter
by Pin1 was significantly diminished when treating
Pin1 enhances TF expression and activity
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Figure 1. Pin1 enhances Tissue Factor (TF) mRNA expression and TF promoter activation by NF-κB and AP-1. (A and B) Expression of the TF gene (F3) in human
umbilical vein endothelial cells (HUVEC) and smooth muscle cells (SMC) after Pin1 overexpression, Pin1 knockdown (siPin1), or treatment with the Pin1 inhibitor
Juglone. HUVECs were treated with TNF-α for 6 hours to induce TF gene expression. (C) Activity of the wild-type TF gene promoter luciferase reporter construct in
PMA-stimulated HEK293T treated with Pin1 inhibitor Juglone or vehicle (DMSO) control. Inset shows schematic representation of the TF gene promoter luciferase
reporter construct.  (D) Activity of the wild-type TF gene promoter luciferase reporter construct after Pin1 overexpression in PMA-stimulated HEK293T and either
vehicle (DMSO), NF-κB signaling inhibitor (BAY-117085), or AP-1 signaling inhibitor (SP600125) treatment. (E and F) Activity of luciferase reporter constructs con-
taining either the wild-type TF gene promoter or the TF gene promoter in which the response element for NF-κB (NF-κB RE) or AP-1 (AP-1 RE) was mutated in PMA-
stimulated HEK293T (E) or TNF-α-stimulated SMCs (F) transiently over-expressing Pin1. (G and H) Activity of the wild-type TF gene promoter luciferase reporter con-
struct after transient overexpression of Pin1 or Pin1 mutants containing a disrupted WW-domain (Pin1:W34A) or lacking isomerase activity (Pin1:K63A) in HEK293T
(G) or SMCs (H) left untreated or stimulated with PMA. Data are shown as mean±Standard Error of Mean. (A-C) P-values were calculated for comparisons between
Pin1 overexpression, Pin1 knockdown (siPin1), or Juglone treatment versus control transduced (Ctrl) or vehicle-treated groups using the two-tailed Student’s t-test.
(D-H) P-values were calculated using one-way ANOVA as indicated. *P<0.05, **P<0.01, ***P<0.001. AU: arbitrary units; mut: mutated.
A B C
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HEK293T cells with inhibitors of NF-κB or AP-1 signaling
(Figure 1D). Similarly, mutating either the NF-κB or AP-1
response element sequences to become non-functional, as
previously described,24 greatly reduced the ability of Pin1
to activate the TF promoter in both HEK293T cells and
SMCs (Figure 1E and F). Finally, neither a Pin1 mutant
with a disrupted WW-domain (Pin1:W34A) nor a Pin1
mutant lacking isomerase activity (Pin1:K63A) could acti-
vate the TF promoter in HEK293T cells or SMCs (Figure
1G and H). 
Taken together, these results show that Pin1 enhances
TF gene expression and TF promoter activation via NF-κB
and AP-1, and that this activation of the TF promoter is
dependent on both Pin1 isomerase activity and a function-
al WW-domain. 
Pin1 interacts with the cytoplasmic domain of Tissue
Factor
The TF cytoplasmic domain (TFCD) contains the well-
conserved Ser258-Pro259 amino acid motif, which may
function as a recognition site for Pin1 when Ser258
becomes phosphorylated (Figure 2A). We performed co-
immunoprecipitation experiments in human SMCs and
PMA-activated HUVECs, which showed that a pull-down
K. Kurakula et al.
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Figure 2. Pin1 interacts with Tissue Factor
(TF) via the twenty-amino acid cytoplasmic
domain (TFCD). (A) Amino acid sequence sim-
ilarity of the TFCD in different species, show-
ing strong conservation of the Pin1 recogni-
tion motif Ser/Thr-Pro (box). (B) Co-immuno-
precipitation (CoIP) for TF and Pin1 in human
PMA-stimulated HUVECs or smooth muscle
cells (SMC) with control IgG or anti-Pin1 anti-
body (IP: IgG/Pin1) and analyzed by western
blot with anti-TF antibody. Input TF and Pin1
levels are also shown. (C) CoIP for TF and Pin1
in HEK293T whole cell lysates over-expressing
HA-tagged Pin1 and either full-length TF or
TF∆CD using anti-HA antibody (IP: HA-Pin1) ana-
lyzed by western blot with anti-TF antibody.
Input TF/TF∆CD and HA-Pin1 levels are also
shown.  (D) Pull-down assay with biotinylated
peptides encoding wild-type human TFCD (WT)
or TFCD with an S258A mutation. Full-length
Pin1, Pin1 mutants with a disrupted WW-
domain (Pin1:W34A) or lacking isomerase
activity (Pin1:K63A), or GFP (as a negative
control) were detected by western blot.  (E)
Pull-down assay with cysteine-linked TFCD-
encoding peptides that were unphosphorylat-
ed or phosphorylated at either Ser253 or
Ser258. Full-length Pin1 and GFP (as a nega-
tive control) were detected by western blot.
A
B
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with anti-Pin1 antibody resulted in co-precipitation of
endogenous TF, while a pull-down with control IgG anti-
body did not, thereby indicating that TF and Pin1 interact
in these two cell types (Figure 2B). Next, we performed
co-immunoprecipitation experiments in HEK293T cells
over-expressing HA-tagged Pin1 and either wild-type TF
or truncated TF lacking the cytoplasmic domain (TFDCD).
These experiments showed that full-length TF interacts
with Pin1, while the TFDCD mutant does not, indicating
that the TFCD is involved in the interaction with Pin1
(Figure 2C). Next, we performed pull-down assays with
biotinylated peptides encoding the human TFCD, which
confirmed our finding that Pin1 interacts with the TFCD,
and showed that this interaction was completely disrupt-
ed by mutating the Ser258 residue in the TFCD (Figure
2D). This result is consistent with the observation that this
Pin1 enhances TF expression and activity
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Figure 3. Nuclear magnetic resonance (NMR) spectroscopy shows interaction between twenty-amino acid cytoplasmic domain (TFCD) and Pin1 requires phospho-
rylation of Ser258 and trans-configuration of the pSer258-Pro259 peptide bond in the TFCD. (A) Superimposition of the assigned 1H/15N HSOC spectra of the Pin1
WW-domain with double phosphorylated TFCD (pSer253/pSer258) showing the chemical shift changes upon increasing amount of peptide to a 10x molar excess.
A non-linear regression fit of the Ser18 (peak shift shown in black dotted box) was used to calculate the binding constant of the complex. (B) Bundle of 20 NMR con-
formers sampling into two major conformers. Sidechains of Pro259 (TFCD), Arg21 and Trp34 (Pin1 WW-domain) are indicated with circles.  (C) Representative models
of the two lowest-energy conformations from (B) are shown in green and magenta. The polypeptide backbones are shown as ribbons. Pin1 WW-domain residues are
underlined. (D) Contact of the TFCD pSer258-Pro259 motif with the Pin1 WW-domain loop1 and comparison of NMR and X-ray structures.
A
B C D
residue is part of a Pin1 recognition motif. Furthermore,
the interaction was not disturbed by mutations in either
the WW-domain or isomerase domain of Pin1 Pin1:W34A
and Pin1:K63A, respectively (Figure 2D). Finally, these
interactions were specific, as control pull-downs without
peptide did not precipitate Pin1, nor did TFCD peptides
precipitate green fluorescent protein (GFP), a protein not
predicted to bind the TFCD (Figure 2D). 
We next investigated the effect of phosphorylation on
the interaction between Pin1 and TF using cysteine-linked
peptides encoding the TFCD with varying states of phos-
phorylation. These experiments suggest that Pin1 has the
highest affinity for the TFCD peptide phosphorylated at
Ser258 (Figure 2E). However, it should be noted that these
co-immunoprecipitation experiments are not quantitative.
Furthermore, the observation that Pin1 seems to bind
unphosphorylated and Ser253-phosphorylated TFCD
peptides may also be due to TF-phosphorylating kinases
present in the whole-cell lysates used for these pull-
downs. The pull-down reactions were specific, as neither
a pull-down without peptide or a pull-down for GFP
resulted in precipitation of the target protein (Figure 2E).
Taken together, these results confirm that Pin1 interacts
with TF and strongly suggest that this interaction involves
the predicted pSer258-Pro259 Pin1 recognition motif in
the TFCD.
Structural modalities mediating Pin1–TFCD complex
formation
To study the interaction between the TFCD and Pin1 in
more detail, we performed isothermal titration calorime-
try (ITC) with Ser253 or Ser258-phosphorylated TFCD-
encoding peptides and purified Pin1 WW-domain (Online
Supplementary Figure S1). Consistent with our pull-down
experiments, these assays showed that the Pin1 WW-
domain interacts specifically with the TFCD peptide
phosphorylated at Ser258 with a fitted Kd of approximate-
ly 137 mM (Online Supplementary Figure S1B and D).
To characterize the molecular basis of the WW-
domain/TFCD interactions, we titrated the 15N-labeled
WW-domain with an increasing concentration of
pSer253/pSer258 TFCD peptide. Analysis of the 2D 1H/15N
heteronuclear single-quantum correlation (HSQC) spectra
showed that in all titrations, binding kinetics were in the
fast-to-intermediate exchange regime, with at least 11
residues showing a large chemical shift (δg > 0.1 ppm)
(Figure 3A). Affected residues in the Pin1 WW-domain
were located at the C-terminus of the β1-strand (S16), the
β1-β2 loop (R17, S18, and G20), the β2-strand (R21, Y23,
and F25), and the C-terminus of the β3-strand (W34 and
E35) (Figure 3A; residues in bold). During our NMR titra-
tions, the 1H/15N HSQC spectra showed line broadening
for the Arg17 peak, resulting in its disappearance (Figure
3A). We attribute the broadening of the Arg17 line to its
close proximity with the TFCD, with interactions occur-
ing in the intermediate exchange regime in the NMR time
scale (Figure 3B). A Kd of 133 ± 13 µM was determined
from the δg (ppm) for HN changes in Pin1 WW-domain
residue Ser18 (Figure 3A; box around moving chemical
shift and inset graph), which is similar to our calorimetric
measurements showing a fitted Kd value of ~137 mM
(Online Supplementary Figure S1). 
We next prepared 13C/15N- isotopically-labeled Pin1
WW-domain in complex with double phosphorylated
pSer253/pSer258 TFCD peptide for sequential backbone
assignment and NMR structure determination. Analysis of
the Cα and Cβ values based upon the weighted chemical
shift index highlighted the three β-strands, which are char-
acteristic of WW-domains (Online Supplementary Figure
S2A). A total of 203 unique intra- and intermolecular dis-
tance constraints were derived from the analysis of the
NOE spectroscopy (NOESY) experiments. We used these
constraints together with the weighted chemical shift
index (Online Supplementary Table S1 and Online
Supplementary Figure S2A) to calculate the solution struc-
ture of the Pin1 WW-domain and TFCD complex (see
Methods for more details). The 20 lowest energy con-
formers of the Pin1 WW-domain yielded a root-mean-
square deviation (RMSD) of 1 Å (residues 6-39) (Figure 3B
and Online Supplementary Figure S2B). The Pin1 WW-
domain is a canonical WW-domain18 consisting of three
twisted anti-parallel β-sheet strands with a conserved Trp-
Trp motif located at the N-terminus of the first 
β-strand and C-terminus of the third β-strand, respective-
ly. 
Analysis of the Pin1 WW-domain–TFCD complex
reveals that TFCD residues Asn257, pSer258 and Pro259
are involved in the binding interface of the Pin1 WW-
domain, consistent with our pull-down assays. While the
Pin1 WW-domain as a whole shows a well-defined, single
conformation, the β1-β2 loop1 binding region of the WW-
domain (residues 17 to 21) and the pSer258-Pro259 motif
of TFCD show two distinct ensembles of conformers
(Figure 3B and C), consistent with the fact that less NOEs
were detected for the β1-β2 loop1. The features that prin-
cipally drive the complex formation are the charge-charge
interaction and the hydrophobic interaction between
Trp34 (the second invariant Trp of the WW motif) with
invariant Pro259. The ionic interactions between the
phosphate of pSer258 with the positively charged guani-
dinium groups of Arg14, Arg17, and Arg21 also appeared
to stabilize the complex. However, as mentioned earlier,
the resonances for Arg17, located at position 1 of loop1,
disappeared during the NMR titration due to intermediate
exchange in the NMR timescale (Figure 3A), suggesting
high flexibility around loop1. Arg21 connects loop1 to the
β2-strand into two conformations and involves multiple
polar contacts with the double phosphorylated TFCD at
pSer258 (Figure 3B and C). Similarly, Trp34-driven
hydrophobic packing of Pro259 induces two ensembles of
Trp34 side chain rotamers and Pro259 configurations, and
both ensemble states still adopt a trans-configuration of
the pSer258-Pro259 peptide bond (Online Supplementary
Table S1). For comparison, the previously determined
interactions of Pin1 WW-domain with Cell division cycle
25 (Cdc25) and the C-terminal domain of the RNA poly-
merase II largest subunit (RNAP II-CTD) are also shown
(Figure 3D).29,30
In order to further confirm the reliability of our struc-
tures, step-wise energy minimization was performed on
all Pin1 WW-domain-TFCD complexes. The RMSD of
heavy atoms/all atoms before and after energy minimiza-
tion was less than 0.45 Å, while the RMSD of the back-
bone was less than 0.3 Å (Online Supplementary Figure
S2B). Therefore, the interactions between the Pin1 WW-
domain and the TFCD, such as the electrostatic interac-
tions with pSer258 and the hydrophobic interactions of
Pro259 with the WW-domain are consistent with the
NMR structures calculated. The trans conformation of the
pSer258-Pro259 peptide bond in the TFCD was stable dur-
K. Kurakula et al.
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ing 10,000 steps of energy minimization, further demon-
strating that our structures satisfy energy-of-motion
(EOM) criteria with reasonable convergence parameters.
Taken together, our structural analyses show the inter-
action between TFCD and Pin1 involves phosphorylation
of Ser258 and trans-configuration of the pSer258-Pro259
peptide bond in the TFCD.
Pin1 extends TF protein half-life via the TFCD
Given our findings that Pin1 and TF interact and that
Pin1 is known to enhance the protein half-life of several of
its substrates,18 we sought to determine the effect of Pin1
on TF protein half-life using full-length TF and TF lacking
the cytoplasmic domain in cycloheximide-treated
HEK293T cells. Pin1 significantly enhanced the protein
half-life of full-length TF (Figure 4A), but not that of TFDCD
(Figure 4B). Furthermore, Pin1 mutants with an inactive
WW-domain (Pin1:W34A) or lacking isomerase activity
(Pin1:K63A) were both still able to enhance the protein
half-life of full-length TF (Figure 4A). Similar effects of
Pin1 and Pin1 mutants on TF protein half-life were
observed for endogenous TF protein in PMA-stimulated
Pin1 enhances TF expression and activity
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Figure 4. Pin1 increases Tissue Factor (TF) protein half-life via the twenty-amino acid cytoplasmic domain (TFCD). (A) HEK293T cells over-expressing full-length TF
with or without Pin1 or Pin1 mutants were treated with cycloheximide (CHX) for times indicated in hours (hrs). TF protein levels were determined by western blot. The
graph shows the amount of TF protein remaining after CHX treatment as a percentage of the starting TF protein level. (B) HEK293T cells over-expressing TF∆CD with
or without Pin1 were treated with CHX for times indicated. TF protein levels were determined by western blot. The graph shows the amount of TF protein remaining
after CHX treatment as a percentage of the starting TF protein level. (C) PMA-stimulated smooth muscle cells (SMC) over-expressing Pin1 or Pin1 mutants were treat-
ed with CHX for times indicated. Endogenous TF protein levels were determined by western blot. The graph shows the amount of TF protein remaining after CHX treat-
ment as a percentage of the starting TF protein level. Data are shown as mean±Standard Error of Mean. P-values were calculated using two-way ANOVA. *P<0.05,
**P<0.01, ***P<0.001 versus Mock-transfected controls.
A
B
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SMCs (Figure 4C). These results indicate that Pin1 can sta-
bilize TF, and that this stabilization is dependent on inter-
action of Pin1 with the TFCD, but is not necessarily
dependent on Pin1 isomerase activity.
Pin1 enhances TF pro-coagulant activity via the TFCD
Having established that Pin1 enhances TF gene expres-
sion and TF protein half-life, we next examined the
impact of Pin1 on the pro-coagulant activity of TF. We
measured the Factor Xa-generating potential of the EC-
RF24 cell line and primary human ECs and SMCs after
Pin1 gain and loss-of-function. Pin1 overexpression
markedly increased TF pro-coagulant activity in both ion-
omycin-treated SMCs and TNF-α treated EC-RF24 cells
and ECs (Figure 5A-C). In contrast, knockdown of Pin1 by
siRNA or inhibition of Pin1 isomerase activity by Juglone
attenuated the TNF-α induced pro-coagulant activity of
TF in these cells (Figure 5A-C). Furthermore, using SMCs
derived from wild-type mice and mice expressing the
TFDCD truncated protein from the endogenous TF gene
locus,23 we found that Pin1 can increase the activity of full-
length TF, but not that of TF lacking the cytoplasmic
domain (Figure 5D). Taken together, these results show
that Pin1 interaction with TF via the TFCD strongly
increases the pro-coagulation activity of TF.
Discussion
Tissue Factor plays a crucial role in initiating the extrin-
sic blood coagulation cascade. Therefore, detailed knowl-
edge of the interacting proteins that modulate TF activity
in vascular cells is essential to understand the regulation of
thrombus formation under pathological conditions and
may lead to novel intervention strategies for thrombotic
disease. Here, we show that the peptidyl-prolyl isomerase
Pin1 both enhances TF gene expression via activation of
NF-κB and AP-1 signaling and directly interacts with TF
through a well-conserved phosphorylated Ser258-Pro259
motif in its cytoplasmic domain. We elucidate the struc-
tural details of this interaction and show that Pin1 increas-
es both the protein half-life and pro-coagulant activity of
TF in vascular cells. Additional effects of Pin1 on TF activ-
ity may come from protease-activated receptor 2-induced
release of TF on microvesicles, which was not studied in
our experiments but were recently described.31
We demonstrate that Pin1 is a potent activator of TF
gene expression in activated ECs and SMCs. The promot-
er of the human TF gene contains transcription factor
binding sites for NF-κB, AP-1, Sp-1 and Egr-1, which are
essential for inducing TF expression in many cell types.9,24
Interestingly, Pin1 has been shown to bind and regulate
the activity of all four of these transcription factors in a cell
type-dependent manner.15 The deletion of Egr-1 and Sp1
response elements in the TF promoter constructs revealed
that there is a complete abrogation of TF promoter activi-
ty (data not shown). Therefore, the effect of Pin1 on activa-
tion of the TF gene promoter by Egr-1 and Sp1 cannot be
determined.
Concerning our detailed structural analyses, we con-
clude that the TFCD-Pin1 WW-domain complex shows a
larger contact area than what was observed in previous
WW-domain/phosphopeptide NMR structures, but simi-
lar to the RNAP II-CTD:Pin1 crystal structure.32 Residues
in the anchoring zone of the Pin1 WW-domain-TFCD
complex showed apparent chemical shift perturbation
(e.g. Tyr23) (Figure 3A),  while these residues were stag-
nant in previous Pin1 NMR titrations.32 This discrepancy
could potentially be the result of titration of the short
pThr-Pro fragment of Cdc25 or tau in these experiments,
rather than the full protein domain that was used here.
Furthermore, the β1-β2 loop1 conformer shows structural
similarity to the isolated ligand-free Pin1 WW-domain X-
K. Kurakula et al.
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Figure 5. Pin1 enhances Tissue Factor (TF) pro-coagulant activity via the twen-
ty-amino acid cytoplasmic domain (TFCD). (A-C) Factor Xa generation as a
measure of TF activity in human human umbilical vein endothelial cells
(HUVECs)  (A), EC-RF24 cells (B), or smooth muscle cells (SMC) (C) after either
overexpression or knockdown of Pin1 or treatment with the Pin1 inhibitor
Juglone for 16 hours (hrs) followed by serum-starvation and treatment with ion-
omycin for 3 hrs (SMCs) or TNF-α for 16 hrs [EC-RF24 and endothelial cells
(ECs)]. (D) Factor Xa generation as a measure of TF activity in mouse SMCs
derived from wild-type mice (WT) or mice expressing TF∆CD from the endogenous
TF gene locus after overexpression of Pin1 and stimulation with ionomycin for 3
hrs.  (E) Summary of Pin1 effects on TF: Pin1 enhances the protein half-life and
pro-coagulant activity of TF through interaction with the conserved pSer258-
Pro259 motif in the TFCD and enhances the activity of the transcription factors
AP-1 and NF-κB to increase TF gene expression. Data are shown as
mean±Standard Error of Mean. P-values were calculated using two-tailed
Student’s t-test (A-C) or two-way ANOVA (D). *P<0.05, **P<0.01, ***P<0.001.
AU: arbitrary units.
A
B
C
D E
ray structures, as well as to the Cdc25 pThr peptide com-
plex NMR structure, suggesting that loop1 undergoes a
thermodynamic switch between ligand-bound and ligand-
free states (Figure 3D).
Our calorimetric experiments revealed a weak interac-
tion between the unphosphorylated TFCD and the Pin1
WW-domain (data not shown), with unphosphorylated
TFCD having a lower affinity for Pin1 (Kd of 1.53 mM)
than double phosphorylated TFCD (Kd of 137 mM).
Similarly, our pull-down assays showed that unphospho-
rylated TF peptides can still pull-down Pin1 protein (Figure
2E). These two results suggest that Pin1 can interact with
TF in both phosphorylation-specific and phosphorylation-
independent manners. It has previously been shown that
pre-attachment of Pin1 to an unphosphorylated “dynamic
anchoring” region of c-Myc that is distant from its pSer-
Pro motif is functionally important for the interaction
between these two proteins.33 It could, therefore, be spec-
ulated that a similar distal, phosphorylation-independent
interaction occurs between Pin1 and TF. Further studies
are needed to confirm whether or not this is indeed the
case.  
It is also important to emphasize that intermolecular
stacking of TFCD trans-Pro259 and Pin1 WW-domain
Trp34 residues is highly orthologous to the intramolecular
stacking between Trp8 and Pro37 of the Pin1 WW-
domain. Given that mutational studies have shown that
Trp8-Pro37 stacking can stabilize the WW-domain fold,32
we think that a similar, but intermolecular trans-Pro259 to
Trp34 interaction-mechanism is utilized to promote the
observed affinity between Pin1 and TF even when TFCD
is unphosphorylated at Ser258. Indeed, complex forma-
tion due to the hydrophobic Pro-Trp stacking with
unphosphorylated Ser-Pro or Ser-Thr motifs is consistent
with previous studies in mammalian cell lines34 and in vitro
studies of the WW-domain binding to unphosphorylated
Ser-Pro motifs such as the cytoplasmic polyadenylation
element binding (CPEB) protein.35,36
In our peptide pull-down and protein half-life experi-
ments, we found that full-length Pin1 as well as Pin1
mutants with a disrupted WW-domain (Pin1:W34A) or
lacking isomerase activity (Pin1:K63A) could bind the
TFCD and stabilize TF protein. The discrepancy between
these findings and our NMR data showing the importance
of the Pin1 Trp34 residue in binding the TFCD can be
explained by the fact that purified Pin1 WW-domain was
used in our NMR studies, and that both domains of Pin1
can recognize and bind pSer-Pro motifs independently of
each other.37 Therefore, it is possible that the Pin1 WW-
domain mutant (Pin1:W34A) interacts with and stabilizes
TF via its isomerase domain. However, whether the inter-
action between TF and Pin1 involves sequential and syn-
ergistic action of the Pin1 WW-domain and isomerase
domain remains to be determined.
Several human and animal studies have shown that TF
plays a crucial role in thrombosis development in vivo. We
demonstrated that Pin1 has a regulatory role in FXa gener-
ation in both activated ECs and SMCs in vitro. Additional
studies with Pin1-deficient mice may further delineate the
role of Pin1 in TF gene expression, TF activity, and coagu-
lation in vivo. However, Pin1-deficient mice already suffer
from decreased body weight, testicular and retinal atro-
phies, and deficiencies in breast proliferative changes dur-
ing pregnancy, which may interfere with in vivo coagula-
tion experiments.38
In summary, our results demonstrate that Pin1 enhances
TF gene expression, interacts with TF via the TFCD, and
positively modulates TF half-life and pro-coagulant activi-
ty in vascular cells. Our findings suggest that Pin1 con-
tributes to a hypercoagulable state in the local and sys-
temic circulation. Specific Pin1 inhibitors could, therefore,
be considered as potential novel therapeutic agents for the
prevention of coagulation-driven pathologies, such as
thrombosis and atherosclerosis.
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